Innovative Cough Simulation System Enhances Understanding of Tuberculosis Transmission

Researchers at Hackensack Meridian and MIT have developed a novel cough simulation system that accurately replicates tuberculosis transmission, advancing disease study and prevention strategies.
Tuberculosis (TB) remains a major global health challenge, causing over a million deaths annually and continuing to be the leading infectious killer worldwide. Although treatments have advanced, understanding the precise mechanisms of TB spread at the droplet level has been difficult. To address this, researchers at Hackensack Meridian Center for Discovery and Innovation (CDI), in collaboration with MIT and Weill Cornell Medicine, have developed the Transmission Simulation System (TSS). This groundbreaking system replicates the airborne transmission of TB by accurately mimicking the human cough, allowing scientists to study the disease's spread with unparalleled precision.
Led by Dr. Martin Gengenbacher, the team published their findings in the journal mBio. The TSS stands out because it can simulate the key characteristics of a human cough, including the propulsion of aerosolized infectious droplets, and uses a nose-only collection method to ensure consistent and realistic transmission conditions. This innovative approach enables detailed study of how TB bacteria travel through the air, survive, and infect new hosts.
Dr. Gengenbacher explained that the major breakthrough of the TSS is its ability to produce aerosol concentrations and particle size distributions similar to those found in active TB patients. Unlike earlier models that exposed animals to dense, uncontrolled bacterial fog, this system provides a controlled environment to investigate specific vulnerabilities of TB bacteria during airborne transmission. Such insights could be vital for developing new strategies to prevent the spread of TB.
The potential applications of the TSS extend beyond TB. By reliably simulating human-to-human transmission, it opens new avenues for testing interventions against various airborne or droplet-borne diseases. CDI's Chief Scientific Officer, Dr. David Perlin, emphasized that this technology could help better understand and control other infectious diseases transmitted through the air.
This innovative system offers a significant step forward in public health research, providing a more accurate platform for studying disease transmission and developing targeted interventions. It marks a promising advancement in efforts to control and eventually eradicate tuberculosis worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Confirms Lebrikizumab's Safety and Effectiveness for Patients with Skin of Color and Eczema
A recent study confirms that lebrikizumab is safe and highly effective for patients with skin of color suffering from eczema, showing significant skin improvement and quality of life benefits.
Global Call for Equal Valuation of Patients, Caregivers, and Relatives in Healthcare
A new collection by The BMJ highlights the urgent need to value and integrate the lived experiences of patients, caregivers, and families in health decision-making worldwide. Experts call for systemic change to make participatory healthcare a routine practice, promoting equity and inclusivity in health systems.
Red Blood Cells Play Active Role in Blood Clot Contraction, Challenging Old Beliefs
New study uncovers the active role of red blood cells in blood clot contraction, challenging longstanding beliefs and opening new avenues for treating clotting disorders.
August 2023 Marks a Turning Point in the US Drug Overdose Crisis, Study Shows
A groundbreaking study highlights August 2023 as the pivotal point where the US drug overdose crisis began to decline, offering new hope amid ongoing challenges.